Ninestar Announces Completion of Antitrust Review for Sale of Lexmark International II LLC.

Toner News Mobile Forums Toner News Main Forums Ninestar Announces Completion of Antitrust Review for Sale of Lexmark International II LLC.

Tonernews.com, June 25, 2025. USA
  • This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts

  • toner
    Keymaster

    China’s Ninestar Corporation has confirmed that its sale of Lexmark International II LLC has successfully cleared all necessary antitrust reviews, paving the way for the transaction to move forward. The Chinese company, which owns the printer giant Lexmark, previously announced its decision to sell the subsidiary, a move that has now passed regulatory scrutiny from relevant authorities.

    This clearance is a key milestone in the sale process, ensuring that the transaction complies with both domestic and international competition laws. As part of the deal, Lexmarkโ€™s operations are expected to continue under new ownership, with potential impacts on its market strategy, including product development and regional expansion.

    The completion of these reviews signals a shift in the global printing and imaging market, as Xerox is poised to take control of Lexmark. This transition marks a significant phase in Lexmarkโ€™s evolution, with its integration into Xeroxโ€™s portfolio likely to bring strategic synergies and expanded market reach. While the financial terms of the deal remain undisclosed, this move signals a new chapter for both companies as they work to strengthen their position in an increasingly competitive and digital-first market.

     

Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty, or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action based on the content on our site.